Ziv-Aflibercept: A Highly Potent Antagonist of Vascular Endothelial Growth Factor
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Acta Ophthalmologica
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ziv-Aflibercept: A Cost-Effective, Off-Label, Highly Potent Antagonist of Vascular Endothelial Growth Factor
Acta Ophthalmol 2019 Dec 20;[EPub Ahead of Print], AM Mansour, MW Stewart, ME Farah, HA Mansour, J ChhablaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.